Tiger Buford argues founders should invest in competitors to build momentum in orthopedic niches. Sports medicine is hot and less crowded right now, while spine and robotic orthopedics are saturated. Citing a competitor's recent funding can signal market validation to investors.
Chapters
and he made a point that always stuck with me is if you really believe in your company, then you would invest in your competitors in the same space. And I love that. So when you pitch, do you say, oh, our competitor, you know, ABC just got, you know, $5 million investment from this VC. Can you sort of get momentum with the space that you're in?
Yeah, I mean, I think it's, it's clear that various spaces go through periods of being hotter than others. So yeah, I think there's absolutely, absolutely some truth to that, you know, and it's also helpful in, you know, depending on how much information you can find out about that deal, you know, what the terms were and those types of things. But, but yeah, I'd say so. Yeah. I think that's a good thing.
Yeah, that's a good point. The terms are not usually transparent. So it's really hard, really hard to get that information.
It is. It is.
Interesting. I think sports medicine is the hot area now in orthopedics. It's, you know, spine is sort of too competitive. You know, everybody wants a robot, but who cares?